Health & Fitness
Health and Fitness
Health and Fitness
Wed, August 25, 2010Tue, August 24, 2010Mon, August 23, 2010Fri, August 20, 2010Thu, August 19, 2010Wed, August 18, 2010Tue, August 17, 2010Mon, August 16, 2010Fri, August 13, 2010Thu, August 12, 2010Wed, August 11, 2010Tue, August 10, 2010Mon, August 9, 2010Fri, August 6, 2010Thu, August 5, 2010Wed, August 4, 2010Tue, August 3, 2010Mon, August 2, 2010Fri, July 30, 2010Finkelstein Thompson LLP Announces Investigation of SciClone Pharmaceuticals, Inc.
Published in Health and Fitness on Wednesday, August 11th 2010 at 14:01 GMT by Market Wire
WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP announces that it is investigating potential shareholder claims concerning SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) (aSciClonea or the aCompanya).
"had received information about the Companya™s practices suggesting possible violations."
On August 9, 2010, the Company revealed that the Securities and Exchange Commission (SEC) had ainitiated a formal, non-public investigationa and issued subpoenas to SciClone regarding the Companya™s ainteractions with regulators and government-owned entities in China, activities relating to sales in China and documents relating to certain company financial and other disclosures.a The Company also revealed that it had received a letter from the Department of Justice (DOJ) regarding SciClonea™s compliance with the Foreign Corrupt Practices Act (FCPA) and that the DOJ ahad received information about the Companya™s practices suggesting possible violations.a SciClonea™s shares have fallen more than 30% since the Companya™s announcement.
If you are interested in discussing your rights as a SciClone shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.
